Skip to main content

Join The Thyroid Cancer Community and Connect With Other Patients and Caregivers at

Second Opinions: Appointments at Leading Cancer Centers

  • BIDMC: CareConnection at 800-667-5356, Monday-Friday, 8:30-5.
  • Dana Farber Cancer Institute
  • The James OSU - the JamesLine 1-800-293-5066
  • Miami Cancer Institute: New Patient Apts 1-786-596-2000
  • RPCI: 1-800-ROSWELL (1-800-767-9355) to schedule appt/2nd opinion consult or RPCI request a consult online​
  • Dana Farber Virtual Second Opinions
Scroll to Continue

Recommended Articles

Image placeholder title

Kisqali Improves Survival in Premenopausal ER+ Advanced Breast Cancer

Kisqali prolongs survival for Pre-menopausal ER positive HER2 Neg breast cancer. San Antonio 2020 update.

Jemperli

GARNET Study Leads to FDA Approval for Jemperli for Uterine/Endometrial Cancer

Jemperli immunotherapy advances treatment of endometrial cancer, especially those with MSI-H or dMMR defects.